This study is in progress, not accepting new patients
A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- ID
- NCT02550652
- Phase
- Phase 2 Lupus Research Study
- Study Type
- Interventional
- Participants
- About 126 people participating
- Last Updated